RPR-104632 | m-entrepreneurship.com

Product Name :
RPR-104632

Search keywords :
RPR104632

drugId :
null

Target Vo:
Glutamate [NMDA] receptor

Target Vo Short Name :
NMDAR

Moa_Name:
Glutamate [NMDA] receptor antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Aventis

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Nervous System Diseases

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-AKT1(Ser473) Antibody
CDKN2A Antibody
Dynamin 1 Antibody: Dynamin 1 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 97 kDa, targeting to Dynamin 1. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts